Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors (Q43410223)
Jump to navigation
Jump to search
scientific article published on 6 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors |
scientific article published on 6 April 2013 |
Statements
1 reference
Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors (English)
1 reference
C Erlichman
1 reference
M W Saif
1 reference
T Dragovich
1 reference
D Mendelson
1 reference
D Toft
1 reference
F Burrows
1 reference
C Storgard
1 reference
D Von Hoff
1 reference
6 April 2013
1 reference
1 reference
71
1 reference
5
1 reference
1345-1355
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference